title: Do elevated plasma vasoactive intestinal polypeptide (VIP) levels cause small intestinal motor disturbances in humans?
abstract: Increased VIP plasma levels cause severe secretory diarrhea. Moreover, VIP is a major regulator of human intestinal motility. We hypothesized that VIP-mediated intestinal motility disturbances contribute to symptoms in elevated plasma VIP. Ten healthy volunteers were intubated twice with an orojejunal multilumen tube for duodenal manometry, jejunal perfusion of electrolyte and marker solution, and aspiration 10 and 40 cm more distally. All subjects randomly received intravenous infusion of saline and 300 pmol/kg x hr VIP for 5 hr. Results showed that VIP but not saline infusion induced netjejunal sodium secretion, watery diarrhea, and cardiovascular effects (P < 0.04). VIP did not alter intestinal motor activity or the mean duration of the interdigestive motility cycle or of phases I and II but nearly halved the duration of phase III (P = 0.0002). We conclude that increased plasma VIP markedly shortens human phase III activity without influencing other motility parameters. Hence, it is unlikely that VIP-mediated small intestinal motor disturbances cause symptoms in VIPOMA. Yet VIP may contribute to terminate phase III motility.
authors.affiliation: Israelitic Hospital, Hamburg, Germany. keller@ik-h.de
authors.forename: Jutta
authors.initials: J
authors.lastname: Keller
authors.forename: Jan C
authors.initials: JC
authors.lastname: Mueller-Wolf
authors.forename: Keihan
authors.initials: K
authors.lastname: Ahmadi-Simab
authors.forename: Christiane
authors.initials: C
authors.lastname: Fibbe
authors.forename: Ulrich
authors.initials: U
authors.lastname: Rosien
authors.forename: Peter
authors.initials: P
authors.lastname: Layer
mesh_terms: D005769:Gastrointestinal Motility / Q000502:physiology*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D014660:Vasoactive Intestinal Peptide / Q000097:blood*; D003969:Vipoma / Q000503:physiopathology
chemical_list: D014660:Vasoactive Intestinal Peptide
references.citation: J Auton Pharmacol. 1991 Dec;11(6):353-64
references.pmid: 1722215
references.citation: Gastroenterology. 1998 Aug;115(2):370-80
references.pmid: 9679042
references.citation: Dig Dis Sci. 1995 Mar;40(3):678-84
references.pmid: 7895565
references.citation: Eur J Pharmacol. 1997 Aug 20;333(1):87-92
references.pmid: 9311665
references.citation: Aliment Pharmacol Ther. 1994 Oct;8(5):475-88
references.pmid: 7865639
references.citation: Am J Physiol. 1992 Apr;262(4 Pt 1):G690-4
references.pmid: 1566850
references.citation: Am J Physiol. 1995 Oct;269(4 Pt 1):G584-90
references.pmid: 7485511
references.citation: Am J Physiol Gastrointest Liver Physiol. 2001 Feb;280(2):G273-8
references.pmid: 11208550
references.citation: Scand J Gastroenterol. 1977;12(8):993-7
references.pmid: 605359
references.citation: Gastroenterology. 1977 Jul;73(1):23-7
references.pmid: 324861
references.citation: Dig Dis Sci. 1994 Dec;39(12 Suppl):73S-75S
references.pmid: 7995221
references.citation: Am J Physiol. 1996 Oct;271(4 Pt 1):G582-90
references.pmid: 8897876
references.citation: Gastroenterology. 1991 Jan;100(1):99-106
references.pmid: 1983854
references.citation: N Engl J Med. 1993 Oct 7;329(15):1073-8
references.pmid: 8371728
references.citation: Histol Histopathol. 1999 Oct;14(4):1119-34
references.pmid: 10506928
references.citation: Gut. 1984 Nov;25(11):1225-9
references.pmid: 6149978
references.citation: Am J Physiol. 1998 Nov;275(5 Pt 1):G979-83
references.pmid: 9815027
references.citation: Eur J Pharmacol. 1996 Nov 7;315(1):59-64
references.pmid: 8960865
references.citation: Gut. 1994 May;35(5):641-5
references.pmid: 8200557
references.citation: Acta Physiol Scand. 1998 Nov;164(3):317-23
references.pmid: 9853020
references.citation: Arch Physiol Biochem. 2001 Jul;109(3):246-51
references.pmid: 11880929
references.citation: J Clin Invest. 1977 Jun;59(6):1158-66
references.pmid: 864008
references.citation: Am J Physiol. 1992 Oct;263(4 Pt 1):E740-7
references.pmid: 1415694
references.citation: Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1207-11
references.pmid: 8980942
references.citation: Am J Physiol. 1994 Jan;266(1 Pt 1):G31-9
references.pmid: 8304456
references.citation: Neurogastroenterol Motil. 1996 Dec;8(4):299-306
references.pmid: 8959734
references.citation: Neurogastroenterol Motil. 1999 Jun;11(3):235-41
references.pmid: 10354348
references.citation: Am J Dig Dis. 1976 Nov;21(11):957-62
references.pmid: 984017
references.citation: Eur J Pharmacol. 1997 Jun 11;328(2-3):217-27
references.pmid: 9218704
references.citation: J Surg Res. 1995 Jan;58(1):111-5
references.pmid: 7830399
references.citation: Neurogastroenterol Motil. 1997 Sep;9(3):143-50
references.pmid: 9347469
references.citation: Peptides. 1994;15(8):1373-6
references.pmid: 7700839
references.citation: Acta Physiol Scand. 1999 Feb;165(2):225-31
references.pmid: 10090335
references.citation: Am J Physiol. 1996 Sep;271(3 Pt 1):G433-7
references.pmid: 8843766
references.citation: Lancet. 1990 Jun 30;335(8705):1555-7
references.pmid: 1972488
references.citation: Gastroenterology. 1970 Mar;58(3):321-8
references.pmid: 5437985
references.citation: Am J Physiol. 1993 Feb;264(2 Pt 1):G334-40
references.pmid: 8447417
references.citation: J Appl Physiol (1985). 2002 Aug;93(2):592-600
references.pmid: 12133869
references.citation: Dig Dis Sci. 1998 Dec;43(12):2719-26
references.pmid: 9881505
references.citation: Clin Biochem. 2002 Nov;35(8):641-6
references.pmid: 12498999
references.citation: Dig Dis. 1991;9(6):389-95
references.pmid: 1804579
references.citation: Am J Physiol. 1998 Nov;275(5 Pt 1):G897-903
references.pmid: 9815017